GPER1 and breast cancer: Thus, GPER1 has been shown to increase cyclic AMP levels by the activation of adenylyl cyclase in human breast cancer cell lines, such as SKBR3, which lack ERα and ERβ [5] and in transfected human embryonic kidney 293 cells [36, 37].